Biodesix (BDSX) Other financing activities (2019 - 2026)

Biodesix has reported Other financing activities for 8 years, with the latest figure at $28000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities rose 154.55% year-over-year to $28000.0; the trailing twelve-month figure through Mar 2026 stood at $47000.0 (up 27.03% YoY), and the FY2025 full-year result was $30000.0, down 31.82% from the prior year.
• Other financing activities for Q1 2026 stood at $28000.0, down from $585000.0 in the prior quarter.
• The five-year high for Other financing activities was $3.6 million in Q4 2022, with the low at -$880000.0 in Q2 2023.
• Historically, Other financing activities has averaged $310666.7 across 5 years, with a median of $28000.0 in 2026.
• Annual changes were most pronounced in 2022 — Other financing activities surged 9800.0% — and 2023, when it slumped 988.89%.
• Biodesix's Other financing activities stood at $3.6 million in 2022, then slumped by 74.64% to $912000.0 in 2023, then plunged by 64.91% to $320000.0 in 2024, then soared by 82.81% to $585000.0 in 2025, then sank by 95.21% to $28000.0 in 2026.
• The last three Other financing activities figures came in at $28000.0 (Q1 2026), $585000.0 (Q4 2025), and -$582000.0 (Q3 2025), per Business Quant data.